27 related articles for article (PubMed ID: 18225515)
1. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
Xu P; Chen J; Chen Z; Zhou S; Hu P; Chen X; Huang M
PLoS One; 2012; 7(5):e37051. PubMed ID: 22693566
[TBL] [Abstract][Full Text] [Related]
2. [Photodynamic therapy for subretinal neovascular membranes. Communication 2. Results of treatment for complicated myopia].
Avetisov SE; Budzinskaia MV; Kiseleva TN; Kazarian EE; Gurova IV; Smirnova TV; Shcheglova IV; Privivkova EA; Loshchenov VB; Shevchik SA; Kuz'min SG; Vorozhtsov GN
Vestn Oftalmol; 2007; 123(6):8-11. PubMed ID: 18225516
[TBL] [Abstract][Full Text] [Related]
3. [The first results of phase IIA of clinical studies of photodynamic therapy for subretinal neovascular membranes with photosense].
Avetisov SE; Budzinskaia MV; Likhvantseva VG; Gurova IV; Loshchenov VB; Shevchik SA; Kuz'min SG; Vorozhtsov GN
Vestn Oftalmol; 2005; 121(5):6-9. PubMed ID: 16274054
[TBL] [Abstract][Full Text] [Related]
4. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
Parravano M; Oddone F; Tedeschi M; Schiano Lomoriello D; Chiaravalloti A; Ripandelli G; Varano M
Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
[TBL] [Abstract][Full Text] [Related]
5. Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome.
Perentes Y; Van Tran T; Sickenberg M; Herbort CP
Ocul Immunol Inflamm; 2005; 13(2-3):219-24. PubMed ID: 16019682
[TBL] [Abstract][Full Text] [Related]
6. [Photodynamic therapy in retinal angiomatous proliferations].
Kürzinger GR; Lang GK; Lang GE
Klin Monbl Augenheilkd; 2008 Feb; 225(2):159-64. PubMed ID: 18293269
[TBL] [Abstract][Full Text] [Related]
7. [Photodynamic therapy for subretinal neovascular membranes. Communication 1. Results of treatment for age-related macular degeneration].
Avetisov SE; Budzinskaia MV; Kiseleva TN; Kazarian EE; Gurova IV; Smirnova TV; Shchegoleva IV; Loshchenov VB; Shevchik SA; Kuz'min SG; Vorozhtsov GN
Vestn Oftalmol; 2007; 123(6):3-7. PubMed ID: 18225515
[TBL] [Abstract][Full Text] [Related]
8. [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 2].
Zueva MV; Tsapenko IV; Riabina MV; Grinchenko MI; Neroeva NV
Vestn Oftalmol; 2009; 125(4):55-9. PubMed ID: 19824452
[TBL] [Abstract][Full Text] [Related]
9. [Subretinal neovascular membrane in age-related macular degeneration].
Budzinskaia MV; Gurova IV
Vestn Oftalmol; 2006; 122(4):49-54. PubMed ID: 16927789
[No Abstract] [Full Text] [Related]
10. [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 1].
Zueva MV; Tsapenko IV; Riabina MV; Grinchenko MI; Neroeva NV
Vestn Oftalmol; 2009; 125(4):51-4. PubMed ID: 19824451
[TBL] [Abstract][Full Text] [Related]
11. Peripapillary subretinal neovascular membranes: a review.
Lee J; Ferrucci S
Optometry; 2011 Nov; 82(11):681-8. PubMed ID: 21873121
[TBL] [Abstract][Full Text] [Related]
12. Fundus autofluorescence in age-related macular degeneration: an epiphenomenon?
Hopkins J; Walsh A; Chakravarthy U
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2269-71. PubMed ID: 16723433
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
